Ancora Advisors’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5
| Closed | – | – | 2549 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 2451 |
|
|
2021
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 2288 |
|
|
2021
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 2000 |
|
|
2021
Q1 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1668 |
|
|
2020
Q1 | – | Sell |
-5
| Closed | -$1K | – | 1458 |
|
|
2019
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1320 |
|
|
2018
Q4 | – | Sell |
-5
| Closed | – | – | 1225 |
|
|
2018
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1354 |
|